Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.112
Sell
RSI(14)
28.675
Sell
STOCH(KDJ)(9,3,3)
13.196
Oversold
ATR(14)
0.547
Low Volatility
CCI(14)
-116.145
Sell
Williams %R
98.182
Oversold
TRIX(12,20)
-0.932
Sell
StochRSI(14)
0.000
Sell
Surgery Partners Inc
SGRY11.490USD
-0.360-3.04%
Close 03/27, 16:00（ET）Quotes delayed by 15 min
553.32MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Surgery Partners Inc
Currency: USD Updated: 2026-03-27Key Insights
Surgery Partners Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 19.27.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Surgery Partners Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Surgery Partners Inc Highlights
StrengthsRisks
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.61% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.31B.
Fairly Valued
The company’s latest PE is -18.76, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 157.58M shares, decreasing 9.47% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 26.43K shares of this stock.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
19.275
Target Price
+62.66%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-27The current financial score of Surgery Partners Inc is 8.21, ranking 19 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 885.00M, representing a year-over-year increase of 2.38%, while its net profit experienced a year-over-year increase of 86.18%.
Score
Financials
5.49
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
7.98
Growth Potential
10.00
Shareholder Returns
7.60
Surgery Partners Inc's Company Valuation
Currency: USD Updated: 2026-03-27The current valuation score of Surgery Partners Inc is 7.88, ranking 20 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -18.76, which is -27103.64% below the recent high of 5066.67 and -1872.89% above the recent low of -370.17.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 17/75
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-27The current earnings forecast score of Surgery Partners Inc is 8.00, ranking 27 out of 75 in the Healthcare Providers & Services industry. The average price target is 28.00, with a high of 36.00 and a low of 18.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
19.275
Target Price
+62.66%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
7
Median
9
Average
Company name
Ratings
Analysts
Surgery Partners Inc
SGRY
12
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-27The current price momentum score of Surgery Partners Inc is 6.36, ranking 57 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 14.44 and the support level at 9.99, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
11.874
Sell
MA10
12.062
Sell
MA20
12.841
Sell
MA50
14.212
Sell
MA100
15.391
Sell
MA200
18.682
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-27The current institutional shareholding score of Surgery Partners Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 121.83%, representing a quarter-over-quarter increase of 6.85%. The largest institutional shareholder is The Vanguard, holding a total of 7.55M shares, representing 5.83% of shares outstanding, with 4.52% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Bain Capital Private Equity, LP
Janus Henderson Investors
King Street Capital Management, L.P.
Pentwater Capital Management LP
UBS Financial Services, Inc.
Fidelity Management & Research Company LLC
BlackRock Institutional Trust Company, N.A.
Dimensional Fund Advisors, L.P.
ClearBridge Investments, LLC
1
2
Risk Assessment
Currency: USD Updated: 2026-03-27The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Surgery Partners Inc is 5.46, ranking 42 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 2.00. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
2.01
VaR
+5.34%
240-Day Maximum Drawdown
+52.01%
240-Day Volatility
+52.74%
Return
Best Daily Return
60 days
+7.68%
120 days
+7.68%
5 years
+29.55%
Worst Daily Return
60 days
-12.34%
120 days
-25.42%
5 years
-25.42%
Sharpe Ratio
60 days
-2.51
120 days
-2.02
5 years
-0.38
Risk Assessment
Maximum Drawdown
240 days
+52.01%
3 years
+74.52%
5 years
+82.86%
Return-to-Drawdown Ratio
240 days
-0.87
3 years
-0.30
5 years
-0.20
Skewness
240 days
-2.93
3 years
-0.02
5 years
+0.40
Volatility
Realised Volatility
240 days
+52.74%
5 years
+56.89%
Standardised True Range
240 days
+6.03%
5 years
+13.36%
Downside Risk-Adjusted Return
120 days
-194.92%
240 days
-194.92%
Maximum Daily Upside Volatility
60 days
+40.08%
Maximum Daily Downside Volatility
60 days
+49.86%
Liquidity
Average Turnover Rate
60 days
+1.37%
120 days
+1.08%
5 years
--
Turnover Deviation
20 days
+44.53%
60 days
+53.87%
120 days
+21.64%
Peer Comparison
Healthcare Providers & Services
Surgery Partners Inc
SGRY
7.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
8.21 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
EHC
8.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pediatrix Medical Group Inc
MD
8.09 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Viemed Healthcare Inc
VMD
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
ENSG
8.06 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
